Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that tofacitinib is an effective and more tolerable treatment than systemic corticosteroids for moderate-to-severe alopecia areata, and its combination with corticosteroids may offer improved efficacy.

This clinical report details the case of a 22-year-old man experiencing severe pustular eruptions on his chest and back, which improved after increasing minocycline to 100 mg twice daily.

Pressure from surgical headrests can cause temporary hair loss in liver donors.

This case study reports a U.S. Naval fighter pilot with recurrent central serous retinopathy who became the first to receive a waiver for unrestricted flight despite permanent defective visual acuity.

This review examines the clinical presentation of alopecia areata in children and compares it to adult-onset cases, noting that data on pediatric cases is scarce and often varies, with reported onset typically between ages 6 and 12.

This case report describes a unique instance where a 9-year-old boy's eyelash trichotillomania was triggered by anxiety about nocturnal enuresis, which was resolved through discussions with family, teachers, and counselors.

The authors describe a case of syncope in a young man after using high strength topical minoxidil, which resolved when he stopped the treatment, highlighting a rare documented reaction.

This report describes a potential association between HAIR-AN syndrome and the onset of manic symptoms in a patient after discontinuing oral contraceptives, though this relationship requires further investigation.

This case report describes post herpetic itch leading to frictional alopecia of the eyebrows and scalp due to frequent rubbing caused by neuropathic itch.

Baricitinib effectively stops hair loss and promotes regrowth in acute alopecia areata.

In this systematic review of 728 patients, the researchers noted that combination therapies involving systemic antibiotics, topical, local, or other systemic agents may yield better outcomes and longer duration of effects for managing Folliculitis decalvans and Tufted Hair Folliculitis compared to systemic antibiotic monotherapy.

This source presents an expert consensus framework for determining which Australian patients with alopecia areata should receive subsidized JAK inhibitor therapy, emphasizing the need for future research including patient perspectives to enhance criteria, ensure fair treatment access, and evaluate real-world outcomes.

This case study highlights the aggressive progression and complex management challenges of metastatic insulinomas, with an emphasis on considering early systemic chemotherapy and advanced therapies like everolimus and PRRT for improved outcomes.

In this study, researchers found that patients with severe alopecia areata who respond to baricitinib treatment within six months may improve clinically within a year, while those with very severe disease may require at least a year for evidence of treatment effect.

In this case study, a 66-year-old woman with hair-related Body Dysmorphic Disorder and newly diagnosed bipolar disorder experienced significant symptom improvement with psychiatric medications, highlighting a unique comorbidity and response to treatment.

This case report describes a 62-year-old female patient with onycholysis whose condition recurred despite taking Coix seed extract, although both initial and recurrent symptoms resolved with its use, suggesting limited efficacy and warranting further study.

This CADTH recommendation advises that Olumiant should be publicly reimbursed for treating severe alopecia areata in adults, provided conditions such as a 50% scalp hair loss and specific prescribing criteria are met.

This study found that while caffeine and adenosine can inhibit hair loss and stimulate hair growth, more research is needed to fully understand the efficacy of shampoo formulations containing specific proportions of these compounds for hair loss treatment and prevention.

In this case report, a 59-year-old man experienced recurrent pericardial effusion linked to minoxidil, with serologic indications of drug-induced lupus erythematosus, underscoring the need for clinicians to consider this rare complication of widespread minoxidil use.

This study found that alopecia areata was associated with increased serum levels of retinol-binding protein-4 compared to controls, but no correlation with disease severity was observed.

This case report details a 17-year-old girl experiencing intermittent swelling, pain, and decreased mobility in her right upper extremity with no clear traumatic or infectious cause, emphasizing diagnostic challenges due to inconclusive tests.

This review highlights the potential benefits of spironolactone in dermatology, particularly for female acne, supporting its safety over long-term use without extensive testing, but presents no new clinical results.

This study found that Malassezia globosa, a scalp-associated fungus linked to dandruff, grows with saturated but not unsaturated fatty acids, potentially causing unsaturated fatty acid accumulation on the scalp and triggering dandruff-like flaking in susceptible individuals.

This review discusses the causes and patterns of telogen effluvium and reports no new clinical findings; it highlights spontaneous recovery in many cases despite severe hair loss.

This article reviews telogen effluvium, including its causes, presentation, and prognosis, and concludes that while chronic cases may be severe, spontaneous recovery can often occur after many years.

This study found that fluoxetine did not demonstrate short-term efficacy in treating trichotillomania in a placebo-controlled, double-blind crossover setting.

In this study, 0.5%-1.0% anthralin cream led to a cosmetic response in 25% of patients with severe alopecia areata, despite common side effects like pruritus and erythema.

In this pilot study, no significant differences were observed between memantine and placebo groups in young adults with Down syndrome on the primary memory outcomes, but some improvement was noted in a secondary measure.

This study concluded that a sequential regimen of prednisolone and cyclophosphamide, followed by low-dose prednisolone and azathioprine, achieved favorable results in most patients with diffuse proliferative and/or membranous lupus nephritis without significant toxicities.

This review discusses two genetic disorders affecting biotin metabolism, each resulting in distinctive skin and hair manifestations, and outlines the associated serious metabolic complications.